Search

everythinglearnresearchcommunity

for

Search:↓

A Brazilian teenager with severe hair loss had total hair regrowth with no side effects after using tofacitinib.

Upadacitinib effectively treats pyoderma gangrenosum.

The framework helps predict adverse effects of blood thinners, improving drug selection for atrial fibrillation.

Janus kinase inhibitors may effectively treat severe alopecia areata unresponsive to other treatments.

Tofacitinib effectively treated severe hair loss in a patient who didn't respond to other treatments.

JAK inhibitors effectively treat severe atopic dermatitis and alopecia areata.

Tyrosine Kinase Inhibitors are effective against cancer but can cause skin, digestive, and blood side effects, including hair loss.

Acinetobacter strain A1-4-2 can safely clean water pollutants.

Targeted cancer drugs can cause skin reactions, so dermatologists must manage these effects.

Axitinib treatment turned a man's grey hair back to black.

Upadacitinib and narrowband UVB effectively treated a child's vitiligo and alopecia areata.

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

Oral tofacitinib effectively treats alopecia areata long-term with manageable side effects.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

Activated ras can protect kidney cells from a certain substance that causes cell death.

Lignans from Urtica triangularis may help treat benign prostatic hyperplasia (BPH).

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

MK-2206 was safe and effectively blocked AKT signaling in cancer patients, warranting more trials.

Upadacitinib may help regrow hair in children with alopecia areata and is generally safe.

VYN201 shows promise as a safe and effective treatment for non-segmental vitiligo.

Tofacitinib is effective and safe for treating severe hair loss in a Saudi population.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Tofacitinib might be used to treat hair loss.

A new topical treatment for hair loss shows strong hair growth effects with low toxicity.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.